Skip to main content
Equibles

OCSAW · Oculis Holding AG · Webcasts, Transcripts & Audio

Track OCSAW — free

Use OCSAW with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research OCSAW.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$2.64 +0.28 (+11.86%) At close · Oct 21
Rebalance outlook locked
Market Cap
$461.29M
Shares
61.59M
Volume · Oct 21 10.87K Avg daily vol (3M) 5365

Oculis Holding AG Webcasts

Earnings calls, investor updates, investor days and conferences for Oculis Holding AG (OCSAW), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Pull transcripts and briefs through the earnings call transcript API or MCP → Add these events to your calendar (.ics)
Earnings call
FY26 · Q3
2026-11-05
Oculis Holding AG (OCSAW) Q3 2026 Earnings Call
Scheduled
Results not yet reported
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-09-16
Oculis Holding AG (OCSAW) September 16, 2026 Conference
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-09-15
Oculis Holding AG (OCSAW) September 15, 2026 Conference
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q2
2026-08-06
Oculis Holding AG (OCSAW) Q2 2026 Earnings Call
Revenue
310,000 CHF
▲ 18.8% YoY
Diluted EPS
-0.16
Rev · 4q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-06-10
Oculis Holding AG (OCSAW) June 10, 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q1
2026-05-29
Oculis Holding AG (OCSAW) Q1 2026 Earnings Call Transcript
Cautious tone OCS-01 Phase 3 DIAMOND results Regulatory strategy for OCS-01 Licaminumab (PREDICT-1) in dry eye
Results not yet reported
Audio Transcript Slides 8-K10-Q
Annual General Meeting
Investor event
2026-05-13
Oculis Holding AG (OCSAW) May 13, 2026 Annual General Meeting Transcript
No reported result — non-financial event
Audio Transcript Slides
Annual General Meeting
Investor event
2026-05-11
Oculis Holding AG (OCSAW) May 11, 2026 Annual General Meeting
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-04-16
Oculis Holding AG (OCSAW) April 16, 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY25 · Q4
2026-03-03
Oculis Holding AG (OCSAW) Q4 2025 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Showing 1–10 of 10 webcasts
Key facts CIK 1953530 CUSIP H5870P102 Visit website Investor relations